FDA Approval Summary: Ado-trastuzumab emtansine for the...

  • Main
  • 2020 / 03
  • FDA Approval Summary: Ado-trastuzumab emtansine for the...
Clinical Cancer Research 2020 / 03

FDA Approval Summary: Ado-trastuzumab emtansine for the adjuvant treatment of HER2-positive early breast cancer

Wedam, Suparna, Fashoyin-Aje, Lola, Gao, Xin, Bloomquist, Erik, Tang, Shenghui, Sridhara, Rajeshwari, Goldberg, Kirsten B., King-Kallimanis, Bellinda L., Theoret, Marc R., Ibrahim, Amna, Amiri-Kordest
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-3980
Date:
March, 2020
File:
PDF, 1.34 MB
2020
Conversion to is in progress
Conversion to is failed